Venture Global's LNG Boom: Record Exports Drive 260% Revenue Surge
Venture Global's (VG) Q3 2025 results show explosive growth with record LNG shipments and major new contracts, though natural gas price volatility keeps profit outlook cautious.
Venture Global's (VG) Q3 2025 results show explosive growth with record LNG shipments and major new contracts, though natural gas price volatility keeps profit outlook cautious.
Eli Lilly partners with MeiraGTx in a $475M deal for a breakthrough gene therapy, AAV-AIPL1, designed to restore vision in children born legally blind.
MannKind Corporation discontinues its Phase 3 ICoN-1 trial for nebulized clofazimine (MNKD-101) in NTM lung disease after futility analysis shows no efficacy. The company will focus on developing its dry powder version, MNKD-102.
Cogent Biosciences announced "transformative" success with their experimental drug, bezuclastinib, in combination with sunitinib, significantly delaying disease progression in patients battling advanced GIST (a form of stomach cancer).